About Summit Biomedical Imaging

About company

Summit Biomedical Imaging improves cancer detection by commercializing PARPi-FL, a PARP1 detecting molecular probe. The company seeks to improve patient care and outcomes by detecting cancer earlier and more accurately. The company was founded in 2016 and is headquartered in New York.